NASDAQ: EXAS Archives

Roche collaboration to accelerate Freenome’s blood-based cancer screening

Medical and Pharmaceutical

Roche collaboration to accelerate Freenome’s blood-based cancer screening

The companies intend to work jointly on improving Freenome’s cell-free DNA cancer tests

Joseph Morton5 days ago

Exact Sciences joins Abbott, shares soar 18% on acquisition and growth prospects

Medical and Pharmaceutical

Exact Sciences joins Abbott, shares soar 18% on acquisition and growth prospects

Abbott earned billions during the Covid-19 pandemic by selling millions of Covid tests and testing kits

Joseph MortonNovember 20, 2025

Lung cancer awareness month: a Mugglehead roundup

Medical and Pharmaceutical

Lung cancer awareness month: a Mugglehead roundup

Throughout November, hospitals, nonprofits, and advocacy groups host awareness events, informational sessions, and fundraising campaigns

Joseph MortonNovember 14, 2025

BioMark Diagnostics pushes for equitable access to early-stage lung cancer testing

Medical and Pharmaceutical

BioMark Diagnostics pushes for equitable access to early-stage lung cancer testing

BioMark showed the importance of expanding access to underserved and remote communities

Joseph MortonNovember 13, 2025

Median Technologies clears hurdle on the way to regulatory acceptance in EU and US

Medical and Pharmaceutical

Median Technologies clears hurdle on the way to regulatory acceptance in EU and US

The company has met a key requirement for regulatory submissions in the US and Europe

Joseph MortonApril 3, 2025

Mugglehead Investment Magazine

All posts tagged "NASDAQ: EXAS"

Medical and Pharmaceutical

Roche collaboration to accelerate Freenome’s blood-based cancer screening

Medical and Pharmaceutical

Exact Sciences joins Abbott, shares soar 18% on acquisition and growth prospects

Medical and Pharmaceutical

Lung cancer awareness month: a Mugglehead roundup

Medical and Pharmaceutical

BioMark Diagnostics pushes for equitable access to early-stage lung cancer testing

Medical and Pharmaceutical

Median Technologies clears hurdle on the way to regulatory acceptance in EU and US

Most Read

Rare Earths

Rare earth yttrium rapidly ascends to record high as supply concerns escalate

Technology

Sunday Robotics emerges from stealth with launch of ‘Memo’ humanoid house chores robot

Bitcoin

Hut 8 Corp unlocks capital from power assets to expand digital pipeline

Alternative Energy

Skyharbour resources partners with Denison Mines in major uranium expansion

Rare Earths

Scientists achieve rare earth elements plant extraction breakthrough

Mugglehead Investment Magazine

All posts tagged "NASDAQ: EXAS"

Medical and Pharmaceutical

Roche collaboration to accelerate Freenome’s blood-based cancer screening

Medical and Pharmaceutical

Exact Sciences joins Abbott, shares soar 18% on acquisition and growth prospects

Medical and Pharmaceutical

Lung cancer awareness month: a Mugglehead roundup

Medical and Pharmaceutical

BioMark Diagnostics pushes for equitable access to early-stage lung cancer testing

Medical and Pharmaceutical

Median Technologies clears hurdle on the way to regulatory acceptance in EU and US

Most Read

Rare Earths

Rare earth yttrium rapidly ascends to record high as supply concerns escalate

Technology

Sunday Robotics emerges from stealth with launch of ‘Memo’ humanoid house chores robot

Bitcoin

Hut 8 Corp unlocks capital from power assets to expand digital pipeline

Alternative Energy

Skyharbour resources partners with Denison Mines in major uranium expansion

Rare Earths

Scientists achieve rare earth elements plant extraction breakthrough

Hut 8 Corp unlocks capital from power assets to expand digital pipeline